RRX
RRX
NYSE · Electrical Equipment

Regal Rexnord Corp

Large-Cap Stocks Blue Chip Stocks Semiconductor Stocks Best Dividend Stocks
$169.07
+8.77 (+5.47%)
As of Nov 7, 1:13 AM ET ·
RRX News3 articles
SELLAS Surges 18.9% as REGAL Trial Nears Pivotal Final Analysis
SELLAS Life Sciences (SLS) shares surged 18.9% over the past week, driven by anticipation of the REGAL trial's final analysis. Market value stands at $3.12 billion, with pipeline valued at $2.98 billion.
Analysis
SELLAS Life Sciences Stock Tumbles 14% on REGAL Trial Uncertainty
SELLAS Life Sciences shares dropped 14% on Friday amid investor caution over the REGAL Phase 3 trial timeline, testing the company's $2.2 billion market cap.
Markets
SELLAS Stock Surges as REGAL Trial Nears Final Analysis
SELLAS Life Sciences shares rose after hours as its REGAL leukemia trial recorded 78 of 80 events needed for final analysis. The company reported a Q1 net loss of $8.4 million but has $107.1 million in cash.
Analysis